| 1 | colorectal | 7,008 |
| 2 | serrated | 156 |
| 3 | head-and-neck | 49 |
| 4 | sloan-kettering | 40 |
| 5 | uadt | 20 |
| 6 | large-bowel | 16 |
| 7 | preterminal | 16 |
| 8 | colo-rectal | 15 |
| 9 | aldosterone-producing | 14 |
| 10 | non-lung | 12 |
| 11 | nonmyeloid | 12 |
| 12 | gs6 | 8 |
| 13 | nonbreast | 8 |
| 14 | antrochoanal | 7 |
| 15 | brca-related | 5 |
| 16 | noncolorectal | 5 |
| 17 | biliary-tract | 4 |
| 18 | hepato-biliary-pancreatic | 4 |
| 19 | non-colorectal | 4 |
| 20 | docetaxel-resistant | 3 |
| 21 | er-breast | 3 |
| 22 | fat-breast | 3 |
| 23 | lip-mouth-pharynx | 3 |
| 24 | lower-lobe | 3 |
| 25 | non-hypoxemic | 3 |
| 26 | 'vulvar | 2 |
| 27 | anthracycline-sensitive | 2 |
| 28 | brca1/2-associated | 2 |
| 29 | cancer/national | 2 |
| 30 | cervix-uterine | 2 |
| 31 | non-glottic | 2 |
| 32 | non-prostate | 2 |
| 33 | nononcological | 2 |
| 34 | ovarian/tubal | 2 |
| 35 | prl-3-driven | 2 |
| 36 | r0/1 | 2 |
| 37 | 'intensified | 1 |
| 38 | 'penile | 1 |
| 39 | 2011.cervical | 1 |
| 40 | 266/322 | 1 |
| 41 | 30,991 | 1 |
| 42 | 421/440 | 1 |
| 43 | 4865 | 1 |
| 44 | aa-specific | 1 |
| 45 | abdomino-peritoneal | 1 |
| 46 | adenoma-associated | 1 |
| 47 | adenoma-colorectal | 1 |
| 48 | ana-negative | 1 |
| 49 | angeles-prostate | 1 |
| 50 | anticolonic | 1 |
| 51 | brafv600e-mutated | 1 |
| 52 | brb-treated | 1 |
| 53 | cell-lung | 1 |
| 54 | colorecal | 1 |
| 55 | colorectal/breast | 1 |
| 56 | colorectal/breast/cervical | 1 |
| 57 | colorectal/colon | 1 |
| 58 | commonly-associated | 1 |
| 59 | cp-sensitive | 1 |
| 60 | cxr-screen-detected | 1 |
| 61 | dsg3-associated | 1 |
| 62 | erbb-3-targeted | 1 |
| 63 | esophageal/gastric/colorectal | 1 |
| 64 | extra-crc | 1 |
| 65 | extra-thyroidal | 1 |
| 66 | familial-non-brca1/2 | 1 |
| 67 | fgfr3-associated | 1 |
| 68 | fgfr3-dependent | 1 |
| 69 | gastic | 1 |
| 70 | gastroesophageal/gastric | 1 |
| 71 | gastroo-esophageal | 1 |
| 72 | haematology-oncological | 1 |
| 73 | haemtaological | 1 |
| 74 | hematolymphoid | 1 |
| 75 | her2-non-amplified | 1 |
| 76 | hormonosensitive-breast | 1 |
| 77 | mdr-dependent | 1 |
| 78 | multi-nodular | 1 |
| 79 | nf1-associated | 1 |
| 80 | ni-induced | 1 |
| 81 | non-hormone-dependent | 1 |
| 82 | non-hormone-sensitive | 1 |
| 83 | non-ogct | 1 |
| 84 | non-polypoidal | 1 |
| 85 | non-small-cell-lung | 1 |
| 86 | ofcolorectal | 1 |
| 87 | onkologie-pancreatic | 1 |
| 88 | oral/oropharyngeal | 1 |
| 89 | oral/pharyngeal | 1 |
| 90 | ovarian/peritoneal/tubal | 1 |
| 91 | overdiagnosis-finding | 1 |
| 92 | overian | 1 |
| 93 | p31 | 1 |
| 94 | pan-population | 1 |
| 95 | pancreatic-head | 1 |
| 96 | peptide-related | 1 |
| 97 | progestin-dependent | 1 |
| 98 | pten-loss-driven | 1 |
| 99 | qol-breast | 1 |
| 100 | questionnaire-breast | 1 |
| 101 | rat-gastric | 1 |
| 102 | rescreen-detected | 1 |
| 103 | screen-identified | 1 |
| 104 | secondary/partial | 1 |
| 105 | sextant-based | 1 |
| 106 | site-assists | 1 |
| 107 | solid-type | 1 |
| 108 | solid/skin | 1 |
| 109 | stat5-associated | 1 |
| 110 | t3-designated | 1 |
| 111 | t4-designated | 1 |
| 112 | tlr3-positive | 1 |
| 113 | vegf-c-overexpressing | 1 |
| 1 | 'intensified | 1 |
| 2 | 'penile | 1 |
| 3 | 'vulvar | 2 |
| 4 | 2011.cervical | 1 |
| 5 | 266/322 | 1 |
| 6 | 30,991 | 1 |
| 7 | 421/440 | 1 |
| 8 | 4865 | 1 |
| 9 | aa-specific | 1 |
| 10 | abdomino-peritoneal | 1 |
| 11 | adenoma-associated | 1 |
| 12 | adenoma-colorectal | 1 |
| 13 | aldosterone-producing | 14 |
| 14 | ana-negative | 1 |
| 15 | angeles-prostate | 1 |
| 16 | anthracycline-sensitive | 2 |
| 17 | anticolonic | 1 |
| 18 | antrochoanal | 7 |
| 19 | biliary-tract | 4 |
| 20 | brafv600e-mutated | 1 |
| 21 | brb-treated | 1 |
| 22 | brca-related | 5 |
| 23 | brca1/2-associated | 2 |
| 24 | cancer/national | 2 |
| 25 | cell-lung | 1 |
| 26 | cervix-uterine | 2 |
| 27 | colo-rectal | 15 |
| 28 | colorecal | 1 |
| 29 | colorectal | 7,008 |
| 30 | colorectal/breast | 1 |
| 31 | colorectal/breast/cervical | 1 |
| 32 | colorectal/colon | 1 |
| 33 | commonly-associated | 1 |
| 34 | cp-sensitive | 1 |
| 35 | cxr-screen-detected | 1 |
| 36 | docetaxel-resistant | 3 |
| 37 | dsg3-associated | 1 |
| 38 | er-breast | 3 |
| 39 | erbb-3-targeted | 1 |
| 40 | esophageal/gastric/colorectal | 1 |
| 41 | extra-crc | 1 |
| 42 | extra-thyroidal | 1 |
| 43 | familial-non-brca1/2 | 1 |
| 44 | fat-breast | 3 |
| 45 | fgfr3-associated | 1 |
| 46 | fgfr3-dependent | 1 |
| 47 | gastic | 1 |
| 48 | gastroesophageal/gastric | 1 |
| 49 | gastroo-esophageal | 1 |
| 50 | gs6 | 8 |
| 51 | haematology-oncological | 1 |
| 52 | haemtaological | 1 |
| 53 | head-and-neck | 49 |
| 54 | hematolymphoid | 1 |
| 55 | hepato-biliary-pancreatic | 4 |
| 56 | her2-non-amplified | 1 |
| 57 | hormonosensitive-breast | 1 |
| 58 | large-bowel | 16 |
| 59 | lip-mouth-pharynx | 3 |
| 60 | lower-lobe | 3 |
| 61 | mdr-dependent | 1 |
| 62 | multi-nodular | 1 |
| 63 | nf1-associated | 1 |
| 64 | ni-induced | 1 |
| 65 | non-colorectal | 4 |
| 66 | non-glottic | 2 |
| 67 | non-hormone-dependent | 1 |
| 68 | non-hormone-sensitive | 1 |
| 69 | non-hypoxemic | 3 |
| 70 | non-lung | 12 |
| 71 | non-ogct | 1 |
| 72 | non-polypoidal | 1 |
| 73 | non-prostate | 2 |
| 74 | non-small-cell-lung | 1 |
| 75 | nonbreast | 8 |
| 76 | noncolorectal | 5 |
| 77 | nonmyeloid | 12 |
| 78 | nononcological | 2 |
| 79 | ofcolorectal | 1 |
| 80 | onkologie-pancreatic | 1 |
| 81 | oral/oropharyngeal | 1 |
| 82 | oral/pharyngeal | 1 |
| 83 | ovarian/peritoneal/tubal | 1 |
| 84 | ovarian/tubal | 2 |
| 85 | overdiagnosis-finding | 1 |
| 86 | overian | 1 |
| 87 | p31 | 1 |
| 88 | pan-population | 1 |
| 89 | pancreatic-head | 1 |
| 90 | peptide-related | 1 |
| 91 | preterminal | 16 |
| 92 | prl-3-driven | 2 |
| 93 | progestin-dependent | 1 |
| 94 | pten-loss-driven | 1 |
| 95 | qol-breast | 1 |
| 96 | questionnaire-breast | 1 |
| 97 | r0/1 | 2 |
| 98 | rat-gastric | 1 |
| 99 | rescreen-detected | 1 |
| 100 | screen-identified | 1 |
| 101 | secondary/partial | 1 |
| 102 | serrated | 156 |
| 103 | sextant-based | 1 |
| 104 | site-assists | 1 |
| 105 | sloan-kettering | 40 |
| 106 | solid-type | 1 |
| 107 | solid/skin | 1 |
| 108 | stat5-associated | 1 |
| 109 | t3-designated | 1 |
| 110 | t4-designated | 1 |
| 111 | tlr3-positive | 1 |
| 112 | uadt | 20 |
| 113 | vegf-c-overexpressing | 1 |
| 1 | 421/440 | 1 |
| 2 | r0/1 | 2 |
| 3 | p31 | 1 |
| 4 | 30,991 | 1 |
| 5 | familial-non-brca1/2 | 1 |
| 6 | 266/322 | 1 |
| 7 | 4865 | 1 |
| 8 | gs6 | 8 |
| 9 | aa-specific | 1 |
| 10 | non-hypoxemic | 3 |
| 11 | anticolonic | 1 |
| 12 | rat-gastric | 1 |
| 13 | gastroesophageal/gastric | 1 |
| 14 | onkologie-pancreatic | 1 |
| 15 | hepato-biliary-pancreatic | 4 |
| 16 | gastic | 1 |
| 17 | non-glottic | 2 |
| 18 | extra-crc | 1 |
| 19 | pancreatic-head | 1 |
| 20 | ni-induced | 1 |
| 21 | her2-non-amplified | 1 |
| 22 | 'intensified | 1 |
| 23 | screen-identified | 1 |
| 24 | sextant-based | 1 |
| 25 | brb-treated | 1 |
| 26 | nf1-associated | 1 |
| 27 | brca1/2-associated | 2 |
| 28 | dsg3-associated | 1 |
| 29 | fgfr3-associated | 1 |
| 30 | stat5-associated | 1 |
| 31 | adenoma-associated | 1 |
| 32 | commonly-associated | 1 |
| 33 | brca-related | 5 |
| 34 | peptide-related | 1 |
| 35 | t3-designated | 1 |
| 36 | t4-designated | 1 |
| 37 | serrated | 156 |
| 38 | brafv600e-mutated | 1 |
| 39 | cxr-screen-detected | 1 |
| 40 | rescreen-detected | 1 |
| 41 | erbb-3-targeted | 1 |
| 42 | hematolymphoid | 1 |
| 43 | nonmyeloid | 12 |
| 44 | lower-lobe | 3 |
| 45 | 'penile | 1 |
| 46 | cervix-uterine | 2 |
| 47 | solid-type | 1 |
| 48 | non-prostate | 2 |
| 49 | angeles-prostate | 1 |
| 50 | ana-negative | 1 |
| 51 | anthracycline-sensitive | 2 |
| 52 | non-hormone-sensitive | 1 |
| 53 | cp-sensitive | 1 |
| 54 | tlr3-positive | 1 |
| 55 | aldosterone-producing | 14 |
| 56 | overdiagnosis-finding | 1 |
| 57 | sloan-kettering | 40 |
| 58 | vegf-c-overexpressing | 1 |
| 59 | cell-lung | 1 |
| 60 | non-small-cell-lung | 1 |
| 61 | non-lung | 12 |
| 62 | head-and-neck | 49 |
| 63 | ovarian/peritoneal/tubal | 1 |
| 64 | ovarian/tubal | 2 |
| 65 | colorecal | 1 |
| 66 | haemtaological | 1 |
| 67 | haematology-oncological | 1 |
| 68 | nononcological | 2 |
| 69 | 2011.cervical | 1 |
| 70 | colorectal/breast/cervical | 1 |
| 71 | non-polypoidal | 1 |
| 72 | extra-thyroidal | 1 |
| 73 | gastroo-esophageal | 1 |
| 74 | oral/pharyngeal | 1 |
| 75 | oral/oropharyngeal | 1 |
| 76 | abdomino-peritoneal | 1 |
| 77 | secondary/partial | 1 |
| 78 | antrochoanal | 7 |
| 79 | preterminal | 16 |
| 80 | cancer/national | 2 |
| 81 | colo-rectal | 15 |
| 82 | colorectal | 7,008 |
| 83 | adenoma-colorectal | 1 |
| 84 | non-colorectal | 4 |
| 85 | esophageal/gastric/colorectal | 1 |
| 86 | ofcolorectal | 1 |
| 87 | noncolorectal | 5 |
| 88 | large-bowel | 16 |
| 89 | overian | 1 |
| 90 | prl-3-driven | 2 |
| 91 | pten-loss-driven | 1 |
| 92 | solid/skin | 1 |
| 93 | pan-population | 1 |
| 94 | colorectal/colon | 1 |
| 95 | multi-nodular | 1 |
| 96 | 'vulvar | 2 |
| 97 | site-assists | 1 |
| 98 | biliary-tract | 4 |
| 99 | non-ogct | 1 |
| 100 | uadt | 20 |
| 101 | docetaxel-resistant | 3 |
| 102 | fgfr3-dependent | 1 |
| 103 | non-hormone-dependent | 1 |
| 104 | progestin-dependent | 1 |
| 105 | mdr-dependent | 1 |
| 106 | questionnaire-breast | 1 |
| 107 | hormonosensitive-breast | 1 |
| 108 | qol-breast | 1 |
| 109 | er-breast | 3 |
| 110 | fat-breast | 3 |
| 111 | colorectal/breast | 1 |
| 112 | nonbreast | 8 |
| 113 | lip-mouth-pharynx | 3 |